Systematic study of tissue factor expression in solid tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Systematic study of tissue factor expression in solid tumors

Published:2022-08-13 Issue:2 Volume:6 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

de Bono Johann S.¹^ORCID,Harris Jeffrey R.²,Burm Saskia M.³,Vanderstichele Adriaan⁴,Houtkamp Mischa A.³,Aarass Saida²³,Riisnaes Ruth¹,Figueiredo Ines¹,Nava Rodrigues Daniel¹,Christova Rossitza¹,Olbrecht Siel⁴,Niessen Hans W. M.⁵,Ruuls Sigrid R.⁶,Schuurhuis Danita H.³,Lammerts van Bueren Jeroen J.⁷,Breij Esther C. W.³,Vergote Ignace⁴

Affiliation:

1. The Institute of Cancer Research Royal Cancer Hospital London UK

2. Genmab Plainsboro New Jersey USA

3. Genmab Utrecht The Netherlands

4. Department of Gynaecology and Obstetrics, Division of Gynaecologic Oncology University Hospitals Leuven, Leuven Cancer Institute Leuven Belgium

5. Department of Pathology VU Medical Center Amsterdam The Netherlands

6. Lava Therapeutics Utrecht The Netherlands

7. Merus Utrecht The Netherlands

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1699

Reference26 articles.

1. The biology and tumour-related properties of monocyte tissue factor

2. How it all starts: Initiation of the clotting cascade

3. FVIIa:TF Induces Cell Survival via G12/G13-Dependent Jak/STAT Activation and BclXLProduction

4. A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice

5. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis;Drake TA;Am J Pathol,1989

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calotropis procera: A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis;Heliyon;2024-01

2. Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study;Journal of Clinical Oncology;2023-12-20

3. An Antibody–Drug Conjugate Directed to Tissue Factor Shows Preclinical Antitumor Activity in Head and Neck Cancer as a Single Agent and in Combination with Chemoradiotherapy;Molecular Cancer Therapeutics;2023-10-12

4. The unfolded protein response links ER stress to cancer-associated thrombosis;JCI Insight;2023-08-31

5. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer;Biomarker Research;2023-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3